{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1157","meta":{"versionId":"22","lastUpdated":"2017-08-26T01:00:05.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2017-08-26"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1157","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1157"}],"version":"20170826","name":"Orphenadrine","title":"Orphenadrine","status":"active","experimental":false,"date":"2017-08-26T01:00:05-04:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Under Development),(Data Element Scope: Under Development),(Inclusion Criteria: Under Development),(Exclusion Criteria: Under Development)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"994521","display":"12 HR Orphenadrine Citrate 100 MG Extended Release Oral Tablet"}]}]},"expansion":{"identifier":"urn:uuid:af705e0b-59d9-4689-a800-3e68efe61e5c","timestamp":"2023-12-11T02:30:16-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"994521","display":"12 HR orphenadrine citrate 100 MG Extended Release Oral Tablet"}]}}